TipRanks
Biofrontera AG (CH:B8F)
:B8F
Switzerland Market
B8F
Biofrontera
RESEARCH TOOLSreports

Biofrontera (B8F) Income Statement

0 Followers

Biofrontera Income Statement

Last quarter (Q4 2023), Biofrontera's total revenue was €7.45M, an increase of 28.47% from the same quarter last year. In Q4, Biofrontera's net income was €5.92M. See Biofrontera’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
€ 13.19M€ 32.25M€ 25.74M€ 28.79M€ 30.35M
Gross Profit
€ 10.91M€ 25.37M€ 20.98M€ 24.87M€ 26.81M
Operating Expenses
€ 11.93M€ 20.59M€ 19.39M€ 60.21M€ 36.84M
Depreciation and Amortization
€ 648.00K€ 791.00K€ 746.00K€ 3.29M€ 5.33M
EBITDA
€ -560.00K€ 5.57M€ 2.34M€ -12.59M€ -277.00K
Operating Income
€ -1.02M€ 4.78M€ 1.59M€ -15.88M€ -5.61M
Other Income/Expenses
€ -197.00K€ 356.00K€ -44.80M€ 51.56M€ -7.09M
Pretax Income
€ -1.22M€ 5.14M€ -43.21M€ 35.68M€ -12.70M
Net Income
€ -3.96M€ -369.00K€ -44.17M€ 37.75M€ -13.02M
Per Share Metrics
Basic EPS
€ -0.65€ >-0.01€ -0.77€ 0.66€ -0.22
Diluted EPS
€ -0.65€ >-0.01€ -0.77€ 0.65€ -0.22
Weighted Average Shares Outstanding
 6.08M 63.81M 57.47M 57.90M 58.18M
Weighted Average Shares Outstanding (Diluted)
 6.08M 63.81M 57.47M 59.29M 58.18M
Currency in EUR

Biofrontera Earnings and Revenue History